Requip

GSK is a leading global biopharma company focused on uniting science, technology, and talent to get ahead of disease together. The company prioritizes innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease. GSK's research and development efforts are concentrated on the science of the immune system, human genetics, and advanced technologies. Their portfolio includes major products in respiratory, oncology, and infectious diseases, including the Parkinson's disease treatment Requip (ropinirole). GSK operates globally with a significant presence in both developed and emerging markets.